Advisornet Financial’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,500
Closed -$75K 1970
2021
Q2
$75K Hold
4,500
0.01% 863
2021
Q1
$82K Hold
4,500
0.01% 808
2020
Q4
$34K Hold
4,500
﹤0.01% 988
2020
Q3
$17K Sell
4,500
-1,322
-23% -$5.22K ﹤0.01% 1143
2020
Q2
$22K Buy
5,822
+4,500
+340% +$16.2K ﹤0.01% 1092
2020
Q1
$4K Hold
1,322
﹤0.01% 1482
2019
Q4
$6K Buy
+1,322
New +$8.38K ﹤0.01% 1505

Other funds holding ORGO

Advisornet Financial's ORGO Position: Q3 2021 in Review

Advisornet Financial sold out of Organogenesis Holdings (ORGO) in Q3 2021, closing a stake of 4,500 shares — an estimated $75K sold.

Advisornet Financial first reported a position in ORGO in Q4 2019 and held it in 7 quarters. The position peaked at $82K in Q1 2021. 153 funds tracked by Wall St. Rank hold ORGO as of Q3 2021.

  • Advisornet Financial reported no remaining Organogenesis Holdings position as of Q3 2021 after selling out during the quarter.
  • Advisornet Financial sold 4,500 Organogenesis Holdings shares in Q3 2021, an estimated $75K.
  • Advisornet Financial first reported a position in Organogenesis Holdings in Q4 2019 and held it in 7 quarters.
  • Advisornet Financial's Organogenesis Holdings position peaked at $82K in Q1 2021.
  • 153 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2021.

Based on Advisornet Financial's 13F filing for Q3 2021, filed 15 Oct 2021.